Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
CASE REPORT
Year : 2009  |  Volume : 30  |  Issue : 3  |  Page : 116-118

Oxaliplatin-induced lung fibrosis


1 Department of Chest Medicine, P.D. Hinduja Hospital, Veer Savarkar Marg, Mahim (W), Mumbai, India
2 Department of Oncology, P.D. Hinduja Hospital, Veer Savarkar Marg, Mahim (W), Mumbai, India

Correspondence Address:
Arpan Shah
P.D. Hinduja Hospital, Veer Savarkar Marg, Mahim (W), Mumbai
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5851.64259

Rights and Permissions

Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2170    
    Printed115    
    Emailed1    
    PDF Downloaded244    
    Comments [Add]    
    Cited by others 1    

Recommend this journal